Aptinyx Completes Enrollment in Phase 2 Exploratory Study of NYX-783 in Post-Traumatic Stress Disorder by Seini Moimoi | Jun 18, 2020 | Portfolio News
Akebia Therapeutics Announces New Chief Financial Officer https://www.longitudecapital.com/posts/akebia-therapeutics-announces-new-chief-financial-officer/
Vaxcyte Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares by Seini Moimoi | Jun 17, 2020 | Portfolio News
Inflazome CEO Nominated as a Finalist for EY Entrepreneur of the Year in Ireland by Seini Moimoi | Jun 16, 2020 | Portfolio News
Inozyme Pharma Announces Changes to its Board of Directors by Seini Moimoi | Jun 16, 2020 | Portfolio News
